Pinotbio, Inc.
🇰🇷South Korea
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability of NTX-101 in Korean Healthy Volunteers
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Pinotbio, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05041543
- Locations
- 🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of
News
No news found